Review and pooled analysis of studies on -607(C/A) and -137(G/C) polymorphisms in IL-18 and cancer risk

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1107-1115

  Mi, Yuan Yuan ^a   Yu, Qian Qian ^b   Yu, Meng Lei ^c   Xu, Bin ^a   Zhang, Li Feng ^a   Cheng, Wei ^a   Zhang, Wei ^a   Hua, Li Xin ^a   Feng, Ning Han ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Cancer risk; IL 18; Polymorphism

Indexed keywords

INTERLEUKIN 18;

ARTICLE; ASIAN; CANCER RISK; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-18; MALE; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84655175127     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9569-1     Document Type: Article

References (35)

1. Z Mallat P Henry R Fressonnet S Alouani A Scoazec P Beaufils 2002 Increased plasma concentrations of interleukin-18 in acute coronary syndromes Heart 88 5 467 469
2. CA Dinarello 2007 Interleukin-18 and the pathogenesis of inflammatory diseases Semin Nephrol 27 1 98 114
3. A Nilkaeo S Bhuvanath 2006 Role of interleukin-18 in modulation of oral carcinoma cell proliferation Mediators Inflamm 2006 3 67120
4. H Okamura H Tsutsi T Komatsu M Yutsudo A Hakura T Tanimoto 1995 Cloning of a new cytokine that induces IFN-gamma production by T cells Nature 378 6552 88 91
5. H Park D Byun TS Kim YI Kim JS Kang ES Hahm 2001 Enhanced IL-18 expression in common skin tumors Immunol Lett 79 3 215 219
6. N Udagawa NJ Horwood J Elliott A Mackay J Owens H Okamura 1997 Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation J Exp Med 185 6 1005 1012
7. ZB Ye T Ma H Li XL Jin HM Xu 2007 Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma World J Gastroenterol 13 11 1747 1751
8. SA Eissa SA Zaki SM El-Maghraby DY Kadry 2005 Importance of serum IL-18 and RANTES as markers for breast carcinoma progression J Egypt Natl Canc Inst 17 1 51 55
9. D Cho H Song YM Kim D Houh DY Hur H Park 2000 Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates Cancer Res 60 10 2703 2709
10. J Bubeník 2003 Tumour MHC class I downregulation and immunotherapy (Review) Oncol Rep 10 6 2005 2008
11. V Giedraitis B He WX Huang J Hillert 2001 Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation J Neuroimmunol 112 1-2 146 152
12. J Bai Y Zhang M Lin X Zeng Z Wang J Shen 2007 Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: a study in an ethnic Chinese cohort Tissue Antigens 70 5 390 397
13. P Sáenz-López R Carretero F Vazquez J Martin E Sánchez M Tallada 2010 Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients Hum Immunol 71 3 309 313
14. A Samsami Dehaghani K Shahriary MA Kashef S Naeimi MJ Fattahi Z Mojtahedi 2009 Interleukin-18 gene promoter and serum level in women with ovarian cancer Mol Biol Rep 36 8 2393 2397
15. T Khalili-Azad M Razmkhah AF Ghiam M Doroudchi AR Talei Z Mojtahedi 2009 Association of interleukin-18 gene promoter polymorphisms with breast cancer Neoplasma 56 1 22 25
16. K Farhat E Hassen N Bouzgarrou S Gabbouj N Bouaouina L Chouchane 2008 Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients Cytokine 43 2 132 137
17. T Qi Q Wang L Zheng HL Yang J Bao 2008 Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer Nan Fang Yi Ke Da Xue Xue Bao 28 5 754 757
18. YS Wei Y Lan YG Liu H Tang RG Tang JC Wang 2007 Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma Acta Oncol 46 8 1090 1096
19. Y Liu N Lin L Huang Q Xu G Pang 2007 Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer DNA Cell Biol 26 8 613 618
20. C Pratesi MT Bortolin E Bidoli R Tedeschi E Vaccher R Dolcetti 2006 Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type Cancer Immunol Immunother 55 1 23 30
21. A Farjadfar Z Mojtahedi MA Ghayumi N Erfani MR Haghshenas A Ghaderi 2009 Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study Acta Oncol 48 7 971 976
22. LG Nong B Luo L Zhang HB Nong 2009 Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population DNA Cell Biol 28 10 507 513
23. MR Haghshenas SV Hosseini M Mahmoudi M Saberi-Firozi S Farjadian A Ghaderi 2009 IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers J Gastroenterol Hepatol 24 6 1119 1122
24. V Asefi Z Mojtahedi B Khademi S Naeimi A Ghaderi 2009 Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study J Laryngol Otol 123 4 444 448
25. N Nikiteas A Yannopoulos A Chatzitheofylaktou C Tsigris 2007 Heterozygosity for interleukin-18-607 A/C polymorphism is associated with risk for colorectal cancer Anticancer Res 27 6B 3849 3853
26. E Vairaktaris ZC Serefoglou C Yapijakis C Agapi S Vassiliou E Nkenke 2007 The interleukin-18-607A/C polymorphism is not associated with risk for oral cancer Anticancer Res 27 6B 4011 4014
27. E Andrie A Michos V Kalampoki A Pourtsidis M Moschovi S Polychronopoulou 2009 Genetic variants in immunoregulatory genes and risk for childhood lymphomas Eur J Haematol 83 4 334 342
28. AW Bushley R Ferrell K McDuffie KY Terada ME Carney PJ Thompson 2004 Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer Gynecol Oncol 95 3 672 679
29. RC Sobti M Shekari DM Tamandani K Malekzadeh V Suri 2008 Association of interleukin-18 gene promoter polymorphism on the risk of cervix carcinogenesis in north Indian population Oncol Res 17 4 159 166
30. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188
31. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748
32. M Egger G Davey Smith M Schneider C Minder 1997 Bias in metaanalysis detected by a simple, graphical test BMJ 315 629 634
33. PD Pharoah AM Dunning BA Ponder DF Easton 2004 Association studies for finding cancer-susceptibility genetic variants Nat Rev Cancer 4 11 850 860
34. JP Ioannidis 1998 Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials JAMA 279 4 281 286
35. K Dickersin YI Min CL Meinert 1992 Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards JAMA 267 3 374 378